138 related articles for article (PubMed ID: 31932134)
1. Comparison of alpha-spending plans for near real-time monitoring for Guillain-Barré Syndrome after influenza vaccination during the 2010/11 influenza season.
Sandhu SK; Hua W; MaCurdy TE; Franks RL; Avagyan A; Chillarige Y; Wernecke M; Kelman J; Ball R
Vaccine; 2020 Feb; 38(9):2221-2228. PubMed ID: 31932134
[TBL] [Abstract][Full Text] [Related]
2. Surveillance for Guillain-Barré syndrome after influenza vaccination among U.S. Medicare beneficiaries during the 2017-2018 season.
Perez-Vilar S; Wernecke M; Arya D; Lo AC; Lufkin B; Hu M; Chu S; MaCurdy TE; Kelman J; Forshee RA
Vaccine; 2019 Jun; 37(29):3856-3865. PubMed ID: 31122853
[TBL] [Abstract][Full Text] [Related]
3. Near real-time surveillance for Guillain-Barré syndrome after influenza vaccination among the Medicare population, 2010/11 to 2013/14.
Sandhu SK; Hua W; MaCurdy TE; Franks RL; Avagyan A; Kelman J; Worrall CM; Ball R; Nguyen M
Vaccine; 2017 May; 35(22):2986-2992. PubMed ID: 28449973
[TBL] [Abstract][Full Text] [Related]
4. Surveillance for Guillain-Barré syndrome after 2015-2016 and 2016-2017 influenza vaccination of Medicare beneficiaries.
Arya DP; Said MA; Izurieta HS; Perez-Vilar S; Zinderman C; Wernecke M; Alexander M; White T; Su IH; Lufkin B; MaCurdy T; Kelman J; Forshee R
Vaccine; 2019 Oct; 37(43):6543-6549. PubMed ID: 31515146
[TBL] [Abstract][Full Text] [Related]
5. A simulation study of the statistical power and signaling characteristics of an early season sequential test for influenza vaccine safety.
Forshee RA; Hu M; Arya D; Perez-Vilar S; Anderson SA; Lo AC; Swarr M; Wernecke M; MaCurdy T; Chu S; Kelman J
Pharmacoepidemiol Drug Saf; 2019 Aug; 28(8):1077-1085. PubMed ID: 31222967
[TBL] [Abstract][Full Text] [Related]
6. Chart-confirmed guillain-barre syndrome after 2009 H1N1 influenza vaccination among the Medicare population, 2009-2010.
Polakowski LL; Sandhu SK; Martin DB; Ball R; Macurdy TE; Franks RL; Gibbs JM; Kropp GF; Avagyan A; Kelman JA; Worrall CM; Sun G; Kliman RE; Burwen DR
Am J Epidemiol; 2013 Sep; 178(6):962-73. PubMed ID: 23652165
[TBL] [Abstract][Full Text] [Related]
7. Surveillance for Guillain-Barré syndrome after influenza vaccination among the Medicare population, 2009-2010.
Burwen DR; Sandhu SK; MaCurdy TE; Kelman JA; Gibbs JM; Garcia B; Markatou M; Forshee RA; Izurieta HS; Ball R;
Am J Public Health; 2012 Oct; 102(10):1921-7. PubMed ID: 22970693
[TBL] [Abstract][Full Text] [Related]
8. Guillain-Barré Syndrome After High-Dose Influenza Vaccine Administration in the United States, 2018-2019 Season.
Perez-Vilar S; Hu M; Weintraub E; Arya D; Lufkin B; Myers T; Woo EJ; Lo AC; Chu S; Swarr M; Liao J; Wernecke M; MaCurdy T; Kelman J; Anderson S; Duffy J; Forshee RA
J Infect Dis; 2021 Feb; 223(3):416-425. PubMed ID: 33137184
[TBL] [Abstract][Full Text] [Related]
9. Association between Guillain-Barré syndrome and influenza A (H1N1) 2009 monovalent inactivated vaccines in the USA: a meta-analysis.
Salmon DA; Proschan M; Forshee R; Gargiullo P; Bleser W; Burwen DR; Cunningham F; Garman P; Greene SK; Lee GM; Vellozzi C; Yih WK; Gellin B; Lurie N;
Lancet; 2013 Apr; 381(9876):1461-8. PubMed ID: 23498095
[TBL] [Abstract][Full Text] [Related]
10. Risk of Guillain-Barré syndrome after seasonal influenza vaccination and influenza health-care encounters: a self-controlled study.
Kwong JC; Vasa PP; Campitelli MA; Hawken S; Wilson K; Rosella LC; Stukel TA; Crowcroft NS; McGeer AJ; Zinman L; Deeks SL
Lancet Infect Dis; 2013 Sep; 13(9):769-76. PubMed ID: 23810252
[TBL] [Abstract][Full Text] [Related]
11. Risk of Guillain-Barré syndrome after exposure to pandemic influenza A(H1N1)pdm09 vaccination or infection: a Norwegian population-based cohort study.
Ghaderi S; Gunnes N; Bakken IJ; Magnus P; Trogstad L; Håberg SE
Eur J Epidemiol; 2016 Jan; 31(1):67-72. PubMed ID: 26008750
[TBL] [Abstract][Full Text] [Related]
12. Guillain-Barre syndrome, influenza, and influenza vaccination: the epidemiologic evidence.
Vellozzi C; Iqbal S; Broder K
Clin Infect Dis; 2014 Apr; 58(8):1149-55. PubMed ID: 24415636
[TBL] [Abstract][Full Text] [Related]
13. Do delays in data availability limit the implementation of near real-time vaccine safety surveillance using the Clinical Practice Research Datalink?
Leite A; Thomas SL; Andrews NJ
Pharmacoepidemiol Drug Saf; 2018 Jan; 27(1):25-29. PubMed ID: 29193554
[TBL] [Abstract][Full Text] [Related]
14. International collaboration to assess the risk of Guillain Barré Syndrome following Influenza A (H1N1) 2009 monovalent vaccines.
Dodd CN; Romio SA; Black S; Vellozzi C; Andrews N; Sturkenboom M; Zuber P; Hua W; Bonhoeffer J; Buttery J; Crawford N; Deceuninck G; de Vries C; De Wals P; Gutierrez-Gimeno MV; Heijbel H; Hughes H; Hur K; Hviid A; Kelman J; Kilpi T; Chuang SK; Macartney K; Rett M; Lopez-Callada VR; Salmon D; Gimenez-Sanchez F; Sanz N; Silverman B; Storsaeter J; Thirugnanam U; van der Maas N; Yih K; Zhang T; Izurieta H;
Vaccine; 2013 Sep; 31(40):4448-58. PubMed ID: 23770307
[TBL] [Abstract][Full Text] [Related]
15. Implementing near real-time vaccine safety surveillance using the Clinical Practice Research Datalink (CPRD).
Leite A; Thomas SL; Andrews NJ
Vaccine; 2017 Dec; 35(49 Pt B):6885-6892. PubMed ID: 29056424
[TBL] [Abstract][Full Text] [Related]
16. Preliminary results: surveillance for Guillain-Barré syndrome after receipt of influenza A (H1N1) 2009 monovalent vaccine - United States, 2009-2010.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2010 Jun; 59(21):657-61. PubMed ID: 20520590
[TBL] [Abstract][Full Text] [Related]
17. Relationship between Guillain-Barré syndrome, influenza-related hospitalizations, and influenza vaccine coverage.
Iqbal S; Li R; Gargiullo P; Vellozzi C
Vaccine; 2015 Apr; 33(17):2045-9. PubMed ID: 25749247
[TBL] [Abstract][Full Text] [Related]
18. Signals and trends of Guillain-Barré syndrome after the introduction of live-attenuated vaccines for influenza in the US and South Korean adverse event reporting systems.
Lee H; Kim HJ; Choe YJ; Shin JY
Vaccine; 2020 Jul; 38(34):5464-5473. PubMed ID: 32600907
[TBL] [Abstract][Full Text] [Related]
19. Guillain-Barré syndrome following the 2009 pandemic monovalent and seasonal trivalent influenza vaccination campaigns in Spain from 2009 to 2011: outcomes from active surveillance by a neurologist network, and records from a country-wide hospital discharge database.
Alcalde-Cabero E; Almazán-Isla J; García López FJ; Ara-Callizo JR; Avellanal F; Casasnovas C; Cemillán C; Cuadrado JI; Duarte J; Fernández-Pérez MD; Fernández Ó; Merino JA; Montero RG; Montero D; Pardo J; Rodríguez-Rivera FJ; Ruiz-Tovar M; de Pedro-Cuesta J;
BMC Neurol; 2016 May; 16():75. PubMed ID: 27206524
[TBL] [Abstract][Full Text] [Related]
20. Prediction of post-vaccination Guillain-Barré syndrome using data from a passive surveillance system.
Luo C; Jiang Y; Du J; Tong J; Huang J; Lo Re V; Ellenberg SS; Poland GA; Tao C; Chen Y
Pharmacoepidemiol Drug Saf; 2021 May; 30(5):602-609. PubMed ID: 33533072
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
